IDARUBICIN HYDROCHLORIDE vs INLURIYO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. IDARUBICIN HYDROCHLORIDE and INLURIYO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IDARUBICIN HYDROCHLORIDE	INLURIYO
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	IDARUBICIN HYDROCHLORIDE	IMLUNESTRANT TOSYLATE
Manufacturer	Hikma	Eli Lilly and Co
Dosage forms	Injectable	Tablet
Drug class	Anthracycline Topoisomerase Inhibitor	—
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia	Breast Neoplasms

idarubicin hydrochloride inluriyo

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

IDARUBICIN HYDROCHLORIDE

IMLUNESTRANT TOSYLATE

Manufacturer

Hikma

Eli Lilly and Co

Dosage forms

Injectable

Tablet

Drug class

Anthracycline Topoisomerase Inhibitor

—

Boxed warning

None

Treats

Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia

Breast Neoplasms

Frequently asked questions

What is the difference between Idarubicin Hydrochloride and Inluriyo?

Idarubicin Hydrochloride contains Idarubicin Hydrochloride, while Inluriyo contains Imlunestrant Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.